Contract Research Services
AIM Biotech Contract Research Services allow you to apply the power of humanized organ-on-a-chip assays to drug development in critical therapeutic areas. Explore further to learn more about how our BioAvatar Technology maximizes the impact of the most relevant assays used to drive modern therapies in cancer and neurobiology. Investigate new drug targets, identify new drug candidates, develop personalized therapeutics and revolutionize ADME-Tox screens, all with our humanized in-vitro assays.
Come see what our BioAvatars can do for you!
Therapeutic Areas
Cancer
Creation of true human tumor microenvironments that offer precise control over the biochemical and biophysical factors that are critical evaluating cancer biology.
Immuno-oncology
Faithful recapitulation of natural human immune responses to test the killing efficiency of engineered T cells and develop human immune checkpoint blockade therapies.
Vascular Biology
Humanized perfusable microvascular networks enabling control of interstitial flow and concentration gradients to mimic in vivo angiogenic and vasculogenic stimuli.
Neurobiology
Human neurobiology models focused evaluating neurovascular function and transport efficiency of neuroactive drugs for a range of disease states.
Your study. Our lab. Human data.
Contract research services for humanized, organ-on-a-chip studies
Let our expert scientific team accelerate your drug discovery using the power of our humanized BioAvatar Technology in conjunction with idenTx 3D tissue culture chips and plates, all in our state-of-the-art research services lab.
Leveraging our own labs and strong partnership with A*STAR Singapore’s Institute of Molecular and Cell Biology, we will partner with you every step of the way to design, develop, and execute humanized organ-on-a-chip assays to deliver clinically relevant results on time and on budget.
Get Started!
AIM Biotech is a proud partner of A*STAR Singapore’s IMCB.
As an autonomous research institution of Singapore’s Agency for Science, Technology and Research (A*STAR), the Institute of Molecular and Cell Biology (IMCB) is a premier international research center. Continuously fostering close collaboration with global research institutions and business leaders, IMCB leverages Singapore’s resources as an international hub for biomedical research, development & innovation, with core expertise in molecular and cell biology.